PIID: SPE2DP25F6739AWARDDELIVERY ORDERSmall Business
Delivery order SPE2DP25F6739TEVA PHARMACEUTICALS USA, INC.
Recipient:TEVA PHARMACEUTICALS USA, INC.
Overview
Award facts
Net obligations: $990,942
- Type
- Delivery order
- PIID
- SPE2DP25F6739
- Awarded by
- Department of Defense › Defense Logistics Agency › DLA TROOP SUPPORT
- Funded by
- Department of Defense
- Recipient
- TEVA PHARMACEUTICALS USA, INC. (UEI NEN9A34LRHJ5)NORTH WALES, PA
- Product or service (PSC)
- 6505 — DRUGS AND BIOLOGICALS
- Date
- Signed on May 12, 2025
- Period of performance
- May 12, 2025 to May 20, 2025 (potential end May 19, 2025)
- Options
- Base and all options value: $990,942
- Extent competed
- NOT COMPETED
- Solicitation procedures
- ONLY ONE SOURCE
- Set-aside
- No set-aside reported
- Contract pricing
- FIRM FIXED PRICE
- Place of performance
- PARSIPPANY, NJ
- Ordered under
- IDV SPE2DP20D0002 (523 orders recorded under it)
- Modifications
- 0; latest action May 12, 2025
- Obligations by fiscal year of action
- FY2025: $990,942
Description
8511369471!ADENOVIRUS TYPE 4 A
The Department of Defense funded and awarded this contract. DoD contract actions are withheld at the source for about 90 days after signature, so actions signed after Jul 17, 2026 are not yet public.
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded May 12, 2025. View on USAspending · Recipient on SAM.gov
Awardee
UEINEN9A34LRHJ5
CAGE code3V8D7
Business sizeOTHER THAN SMALL BUSINESS
Parent companyTEVA PHARMACEUTICALS USA, INC.
Transaction history
Transaction history
Every modification of this award, with its obligation change and reason.